- Home
- BLTE vs WMK Comparison
BLTE vs WMK Comparison
Compare BLTE & WMK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLTE
- WMK
- Stock Information
- Founded
- BLTE 2018
- WMK 1912
- Country
- BLTE United States
- WMK United States
- Employees
- BLTE N/A
- WMK N/A
- Industry
- BLTE Biotechnology: Pharmaceutical Preparations
- WMK Food Chains
- Sector
- BLTE Health Care
- WMK Consumer Staples
- Exchange
- BLTE Nasdaq
- WMK Nasdaq
- Market Cap
- BLTE 2.1B
- WMK N/A
- IPO Year
- BLTE 2022
- WMK N/A
- Fundamental
- Price
- BLTE $66.70
- WMK $77.12
- Analyst Decision
- BLTE Strong Buy
- WMK
- Analyst Count
- BLTE 4
- WMK 0
- Target Price
- BLTE $96.67
- WMK N/A
- AVG Volume (30 Days)
- BLTE 53.3K
- WMK 138.5K
- Earning Date
- BLTE 03-17-2025
- WMK 05-07-2025
- Dividend Yield
- BLTE N/A
- WMK 1.76%
- EPS Growth
- BLTE N/A
- WMK 5.89
- EPS
- BLTE N/A
- WMK 4.09
- Revenue
- BLTE N/A
- WMK $4,791,730,000.00
- Revenue This Year
- BLTE N/A
- WMK N/A
- Revenue Next Year
- BLTE N/A
- WMK N/A
- P/E Ratio
- BLTE N/A
- WMK $19.04
- Revenue Growth
- BLTE N/A
- WMK 1.64
- 52 Week Low
- BLTE $31.01
- WMK $60.39
- 52 Week High
- BLTE $86.53
- WMK $83.09
- Technical
- Relative Strength Index (RSI)
- BLTE 58.99
- WMK 53.68
- Support Level
- BLTE $64.10
- WMK $74.00
- Resistance Level
- BLTE $67.40
- WMK $78.50
- Average True Range (ATR)
- BLTE 2.33
- WMK 2.00
- MACD
- BLTE -0.33
- WMK -0.51
- Stochastic Oscillator
- BLTE 37.74
- WMK 35.37
About BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.